169 related articles for article (PubMed ID: 4544535)
21. Cell kinetics and chemotherapy in acute leukemia.
Lampkin BC; McWilliams NB; Mauer AM
Semin Hematol; 1972 Apr; 9(2):211-23. PubMed ID: 4502317
[No Abstract] [Full Text] [Related]
22. The generation time of human leukemic myeloblasts.
Greenberg ML; Chanana AD; Cronkite EP; Giacomelli G; Schiffer LM; Stryctmans PA; Vincent PC
Lab Invest; 1972 Mar; 26(3):245-52. PubMed ID: 4502025
[No Abstract] [Full Text] [Related]
23. Combination chemotherapy of acute leukaemia in adults. Comparison of two schedules.
Scand J Haematol; 1974; 12(5):341-5. PubMed ID: 4527707
[No Abstract] [Full Text] [Related]
24. Clinical correlates of in vitro effect of methotrexate on acute leukemia blasts.
Hryniuk WM; Bishop A; Foerster J
Cancer Res; 1974 Oct; 34(10):2823-9. PubMed ID: 4547159
[No Abstract] [Full Text] [Related]
25. [Cell cycle effect of cytosine arabinoside, vincristine, and massive leukapheresis on human leukemic blasts and its application to a quadruple combination chemotherapy of acute leukemia (author's transl)].
Yoshikawa H; Takeyama H; Nagata K; Ueda R; Ishiguro J
Rinsho Ketsueki; 1975 Jan; 16(1):8-18. PubMed ID: 1172041
[No Abstract] [Full Text] [Related]
26. Cell differentiation and therapeutic effect of low doses of cytosine arabinoside in human myeloid leukemia.
Michalewicz R; Lotem J; Sachs L
Leuk Res; 1984; 8(5):783-90. PubMed ID: 6593509
[TBL] [Abstract][Full Text] [Related]
27. An analysis of the relationship of leukemic cell kinetics to chemotherapy.
Killmann SA; Ernst P
Bibl Haematol; 1973; 39():1037-45. PubMed ID: 4777986
[No Abstract] [Full Text] [Related]
28. Low-dose cytosine arabinoside as an alternative treatment for acute leukemia in Jehovah's Witnesses.
Dainer PM; Knupp CL; Sartiano GP
Am J Hematol; 1992 Jun; 40(2):156-7. PubMed ID: 1585917
[No Abstract] [Full Text] [Related]
29. Remission maintenance for acute nonlymphocytic leukemia: cytosine arabinoside plus 6-thioguanine versus a sequence of drug regimens.
Presant CA; Berger NA; Klahr C; Phillips GL
Cancer; 1980 Jul; 46(1):22-8. PubMed ID: 6930320
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of cell proliferation in acute leukemia.
Cheung WH; Rai KR; Sawitsky A
Cancer Res; 1972 May; 32(5):939-42. PubMed ID: 4502172
[No Abstract] [Full Text] [Related]
31. Daunorubicin (NSC-82151), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) combination therapy for advanced adult acute leukemia.
Burns CP
Cancer Chemother Rep; 1975; 59(4):757-60. PubMed ID: 1100227
[No Abstract] [Full Text] [Related]
32. Cell proliferation and protein synthesis in human leukaemic myeloblasts after cytosine arabinoside therapy.
Wantzin GL; Karle H; Killmann SA
Br J Haematol; 1976 Feb; 32(2):283-9. PubMed ID: 1061618
[TBL] [Abstract][Full Text] [Related]
33. [Results in the treatment of acute granulocytic leukemias using a combination of daunorubicine-cytosine arabinoside-cyclophosphamide. Apropos of 35 cases].
Bauters F; Plouvier B; Caulier MT; Mouton J; Goudemand M
Lille Med; 1974 Mar; 19(3):226-31. PubMed ID: 4612276
[No Abstract] [Full Text] [Related]
34. Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria.
Curtis JE; Cowan DH; Bergsagel DE; Hasselback R; McCulloch EA
Can Med Assoc J; 1975 Aug; 113(4):289-94. PubMed ID: 1056807
[TBL] [Abstract][Full Text] [Related]
35. Changes in the characteristics of the bone marrow during therapy for acute non-lymphocytic leukemia: relationship to response to remission induction therapy.
Preisler HD; Raza A; Azarnia N; Rakowsky I; Barcos M; Browman G; Booker L; Goldberg J; Gottleib A; Brennan J
Eur J Cancer Clin Oncol; 1985 May; 21(5):563-71. PubMed ID: 3859416
[TBL] [Abstract][Full Text] [Related]
36. Alterations of granulopoiesis following chemotherapy.
Greenberg P; Bax I; Mara B; Schrier S
Blood; 1974 Sep; 44(3):375-83. PubMed ID: 4527645
[No Abstract] [Full Text] [Related]
37. The relevance of cell kinetics for optimal scheduling of 1-beta-D-arabinofuranosyl cytosine and methotrexate in a slow growing acute myeloid leukemia (BNML).
Aglietta M; Sonneveld P
Cancer Chemother Pharmacol; 1978; 1(4):219-23. PubMed ID: 285766
[TBL] [Abstract][Full Text] [Related]
38. Inhibition by arabinosylcytosine of DNA synthesis in bone marrows of relapsed AML patients.
Brox L; Mowles D; Belch A
Eur J Cancer (1965); 1979 Oct; 15(10):1263-8. PubMed ID: 293261
[No Abstract] [Full Text] [Related]
39. Perturbation of generation cycle of human leukaemic blast cells in vivo by daunomycin.
Ernst P
Scand J Haematol; 1973; 11(1):13-22. PubMed ID: 4518864
[No Abstract] [Full Text] [Related]
40. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
Recent Results Cancer Res; 1973; 43():165-8. PubMed ID: 4531077
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
